Comparative study in the control of bovine viral diarrhea

2018 ◽  
Vol 19 (2) ◽  
pp. 125-133 ◽  
Author(s):  
Mauro Larghi

AbstractBovine viral diarrhea virus (BVDV) is an important infectious agent affecting herd productivity and reproduction, and leading to massive economic losses. As such, BVD is the subject of a number of control and eradication schemes globally. The key elements of such schemes are: diagnosis and removal of persistently infected animals from herds; implementation of biosecurity practices aimed at preventing the introduction or re-introduction of BVDV in free herds; and ongoing surveillance to monitor the progress of the program and to detect new infections. The objective of this review is to examine the impact of BVD and the management of the disease in three countries: Scotland, Spain, and Argentina, where BVD control programs are in distinct phases: established, developing, and yet to be initiated. This work also sets out to highlight potential difficulties and formulate recommendations for successful BVD control. It concludes that a systematic, countrywide approach is needed to achieve a sustainable decrease in BVD prevalence. The role of vaccines in control programs is concluded to be a valuable additional biosecurity measure. This study also concludes that there are potential wider benefits to a systematic BVD control program, such as a reduction in antimicrobial use and increases in the competitiveness of the cattle industry.

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Jacqueline King ◽  
Anne Pohlmann ◽  
Kamila Dziadek ◽  
Martin Beer ◽  
Kerstin Wernike

Abstract Background As a global ruminant pathogen, bovine viral diarrhea virus (BVDV) is responsible for the disease Bovine Viral Diarrhea with a variety of clinical presentations and severe economic losses worldwide. Classified within the Pestivirus genus, the species Pestivirus A and B (syn. BVDV-1, BVDV-2) are genetically differentiated into 21 BVDV-1 and four BVDV-2 subtypes. Commonly, the 5’ untranslated region and the Npro protein are utilized for subtyping. However, the genetic variability of BVDV leads to limitations in former studies analyzing genome fragments in comparison to a full-genome evaluation. Results To enable rapid and accessible whole-genome sequencing of both BVDV-1 and BVDV-2 strains, nanopore sequencing of twelve representative BVDV samples was performed on amplicons derived through a tiling PCR procedure. Covering a multitude of subtypes (1b, 1d, 1f, 2a, 2c), sample matrices (plasma, EDTA blood and ear notch), viral loads (Cq-values 19–32) and species (cattle and sheep), ten of the twelve samples produced whole genomes, with two low titre samples presenting 96 % genome coverage. Conclusions Further phylogenetic analysis of the novel sequences emphasizes the necessity of whole-genome sequencing to identify novel strains and supplement lacking sequence information in public repositories. The proposed amplicon-based sequencing protocol allows rapid, inexpensive and accessible obtainment of complete BVDV genomes.


2021 ◽  
Vol 8 ◽  
Author(s):  
Aleksandra Antos ◽  
Pawel Miroslaw ◽  
Jerzy Rola ◽  
Miroslaw Pawel Polak

Vaccination against bovine viral diarrhea (BVD) is one of the key elements to protect cattle herds from this economically important disorder. Bovine viral diarrhea virus (BVDV) is a pestivirus infecting animals at all ages with significant impact on reproductive, digestive, and respiratory systems. Financial burden caused by this pathogen prompts many farmers to introduce vaccination as the control and prophylactic measure especially when persistently infected (PI) individuals, being the main source of the virus in the herd, are removed after test-and-cull approach. The aim of the study was to compare the serological response in cattle herds where new PI calves were identified without prior removal of PI animals or despite their removal and after the introduction of whole herd vaccination against BVDV infection. Overall seroprevalence in 5 vaccinated herds was 91.7 and 83.3% using ELISA and virus neutralization test, respectively. Despite high titers for both vaccine and field strains of BVDV in analyzed herds the analysis of comparative strength of neutralization indicated that 41.4% of positive samples did not have a predominant titer against one specific subtype of BVDV. In 3 herds BVDV-1b subtype was identified while in 2 others it was BVDV-1d, while the vaccine used was based on BVDV-1a which was never identified in Poland so far. To increase the success of the BVDV eradication program, a careful approach is suggested when planning herd vaccination. Comparison of existing field strains and their similarity with vaccine strains at antigenic and genetic levels can be a useful approach to increase the effectiveness of vaccination and efficient protection of fetuses from persistent infection.


2017 ◽  
Vol 15 (2) ◽  
pp. e05R01 ◽  
Author(s):  
Francisco J. Diéguez ◽  
Manuel Cerviño ◽  
Eduardo Yus

Bovine viral diarrhea virus (BVDV), a member of the genus Pestivirus of the family Flaviviridae, causes significant losses in cattle farming worldwide because of reduced milk production, increased mortality of young animals and reproductive, respiratory and intestinal problems. The virus is characterized by an important genetic, and consequently antigenic and pathogenic diversity. Knowing the variability of viral strains present in a population provides valuable information, particularly relevant for control programs development, vaccination recommendations and even identification of likely infection sources. Such information is therefore important at both local and regional levels. This review focuses on the genetic diversity of BVDV isolates infecting cattle in Spain over the last years. According to the published data, the most prevalent BVDV group in Spain was 1b, and to a lesser extent 1d, 1e and 1f. Besides, BVDV-2 has also been found in Spain with several ratified isolates. The studies carried out in Spain also showed increased genetic heterogeneity of BVDV strains, possibly due to a more intensive use of analytical tools available, presenting studies with increasingly greater sample sizes.


2018 ◽  
Vol 2018 ◽  
pp. 1-5 ◽  
Author(s):  
Yu Deng ◽  
Silu Wang ◽  
Runxia Liu ◽  
Guiying Hao

Bovine viral diarrhea virus (BVDV) affects cows, pigs, sheep, goats, and other ruminants, as well as some wild animals. BVDV causes considerable economic losses every year and many countries have developed programs aimed at the eradication of this disease. The genetic diversity of BVDV in diseased goats has never been described in southwestern China. Thus, in this study, we applied antigen-capture ELISA and RT-PCR to survey the infection rate of BVDV in diseased goats in this region. Our results demonstrated that the average BVDV infection rate in goats was 17.51%, with all positive samples indicating infection by BVDV-1 and not BVDV-2, BVDV-3, or Border disease virus. The molecular characteristics of the 5′-untranslated region (5′-UTR) of BVDV-1 were recognized as belonging predominantly to the BVDV-1a, 1b, 1c, 1m, and 1p subtypes. BVDV-1b and 1m were the most abundant subtypes identified in this region, similar to the BVDV epidemics in cattle in other regions of China. This is the first study that describes the genetic characterization of BVDV in sick goats from southwestern China and is important for future studies and control programs.


2018 ◽  
Vol 44 (1) ◽  
pp. 7
Author(s):  
Rinaldo Batista Viana ◽  
Claudia Del Fava ◽  
Ana Carolina de Barros Moura ◽  
Bruno Moura Monteiro ◽  
Rodrigo Dos Santos Albuquerque ◽  
...  

Background: Viral diseases affecting reproduction cause economic losses in cattle, as reproductive failure interrupts the production cycle, thus reducing herd productivity. Buffaloes are susceptible to most of the diseases that affect cattle. Some of the viral diseases of reproductive importance are infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD), and bovine leukosis (BL). The objective of this study was to determine the seroprevalence of IBR virus (bovine herpes virus-1, BoHV-1), BVD virus (BVDV), and BL virus (BLV) in female buffaloes living in wetland areas or plains in the state of Pará, as well as the seroprevalence of BoHV-1, BVDV, and BLV in females of different age groups.Materials, Methods & Results: It were used 225 crossbred buffaloes from 4 buffalo exclusive farms. The buffaloes reared on farms A (n = 50) and B (n = 89) were kept in wetland areas on Marajó Island (n = 139), Pará. On farms C (n = 30) and D (n = 56) buffaloes were kept in plains (n = 86) in a northeastern mesoregion of Para. Animals were categorized into age groups: I: 0-3 years (n = 34), II: 3-6 years (n = 58), III: 7-9 years (n = 55), and IV: over 9 years (n = 78). Blood samples were collected and sera were sent for processing at the Bovine Virus Laboratory, Biological Institute of São Paulo, Brazil. The presence of IBRV and BVDV was determined by neutralization and BLV antibodies by immunodiffusion in agar gel. Statistical analysis was performed using the Ȥ2 test at a significance level of 5%. Among the seroprevalences of IBRV, BVDV and BLV antibodies, the difference in prevalence for BVD [P < 0.01] was observed between wetland areas and plains of Para, varying from 12.4% to 96.0% and 0.0% to 13.3%, respectively. While levels of IBRV remained high on farms A (79.6%), B (86.5%), C (83.3%) and D (89.1%) [P = 0.60] and BLV was negative in all the animals. BVDV was similar for all the age groups [P = 0.60], while IBRV was more prevalent in animals over 6 years of age with group I: (76.5%), II (74.5%), III (92.3%) and IV (91.3%) [P = 0.01]. It was not possible verify the influence of age in prevalence for BL.Discussion: The prevalence obtained for the BoHV-1 on farms was high, with little variation between 79.6% and 89.1%. The high prevalence of BoHV-1 suggests the free circulation of the virus in the state of Para. Notably, the animals in this study had not been vaccinated, so the determined viral antibody titers were independent of vaccination. BVDV results showed high variation between 0.0% and 96.0%. The highest prevalence in wetland areas may be related to the breeding environment, because of a possible horizontal contamination. The lack of BLV antibodies prevalence can be attributed to the fact that all the evaluated animals were kept in an extensive breeding system where they had little direct contact. The prevalence of IBR was higher in the older animals. Variation in prevalence with age was not observed for BVD. It was concluded that the prevalence for IBR and BVD were high indicating that the etiological agents are circulating in Para, with IBR having a higher prevalence in older animals. Breeding buffalo in wetland areas may favor horizontal transmission of BVDV because facilitate contact of healthy animals with water contaminated by virus carriers animal secretion and the absence of seropositive animals at the BLV does not necessarily indicate that buffaloes are resistant to the virus.


2020 ◽  
Vol 32 (1) ◽  
pp. 108-111
Author(s):  
Jaden M. Carlson ◽  
Brian L. Vander Ley ◽  
Sang I. Lee ◽  
Dale M. Grotelueschen ◽  
Paul H. Walz ◽  
...  

Control of bovine viral diarrhea virus (BVDV) relies on resource-intensive sampling to detect and remove persistently infected (PI) cattle. Herd-level surveillance tools would be useful for herds with unknown BVDV status and for monitoring herds with BVDV-free status. Our objective was to determine the feasibility of using stable flies as a sampling tool to detect BVDV at the herd level. Stable flies ( Stomoxys calcitrans) were fed citrated blood from either BVDV-PI or BVDV-free cattle to establish pools of 100 flies with various proportions of BVDV-fed flies (0%, 1%, 10%, 20%, 40%, or 100% in each pool). BVDV-fed flies in these pools were harvested either 1, 2, or 3 d after consuming BVDV-PI blood to determine the impact of time after feeding. Two replicates of a 3-d by 6-dilution level matrix were produced. BVDV RNA was consistently detected on day 1 when ≥10% of the flies in the pool consumed PI blood. On days 2 and 3, positive BVDV RNA detection was variable and became less consistent. Our results demonstrate that BVDV RNA can be detected in stable flies after feeding on blood from PI cattle. Successful use of stable flies as a surveillance tool will require validation under field conditions.


2008 ◽  
Vol 20 (1) ◽  
pp. 156 ◽  
Author(s):  
A. Bielanski ◽  
J. Algire ◽  
A. Lalonde

Bovine viral diarrhea virus (BVDV) infection affects cattle throughout the world. It causes significant economic losses in the cattle industry. The potential for transmission of a cytopathic biotype of BVDV by in vivo-derived embryos has been thought to be negligible. However, there is no study to prove non-transmission of the most common field isolate of noncytopathic biotype (NCPB) of BVDV by IVF embryos. Here we report on the preliminary outcome of embryo transfer (ET) of IVF embryos exposed in vitro to type-1 (NY-1) and type-2 (P-131) genotypes of NCPB of BVDV. For this experiment, IVF embryos were generated using standard methods which briefly involve: maturation of cumulus–oocyte complexes in TCM medium, fertilization of oocytes with BVDV-free semen, and culture of zygotes to the blastocyst stage in SOF medium without somatic cells. Day 7 blastocysts were exposed for 1 h to NY-1 or P-131 (103–107 TCID50 mL–1) BVDV strains before being washed (without trypsin) as recommended by IETS. Two embryos were transferred on each occasion. Embryo recipients were virus-free and anti-BVDV antibody-free prior to ET. The recipients remained individually in isolation premises after ET. In total, 126 ET procedures were performed resulting in 57 pregnancies and 34 calves born free of the infectious virus and BVDV antibodies (5 pregnancies are still pending). In total, 23 pregnancies were lost after 30 days. Exposure of embryos to type-2 BVDV resulted in a loss of 46% (17/37) of pregnancies after 30 days post-ET and 20 recipients seroconverted to BVDV. Within seroconverted and pregnant animals (n = 14), only 2 recipients maintained pregnancy and delivered uninfected calves at term. In contrast, exposure of embryos to type-1 caused 30% (6/20) of the pregnancy losses after 30 days and did not cause any seroconversion in ET recipients. After washing, 33% (3/9) and 38% (17/44) single embryos from the infected pool of IVF embryos tested positive for the BVDV. In conclusion, under these experimental conditions, a proportion of recipients was apparently infected after receipt of BVDV-exposed embryos. However, all of the calves that survived to term were BVDV-free and anti-BVDV antibody free.


Viruses ◽  
2021 ◽  
Vol 13 (12) ◽  
pp. 2431
Author(s):  
Yusuke Goto ◽  
Gakuji Yaegashi ◽  
Kazuhiro Fukunari ◽  
Tohru Suzuki

Bovine viral diarrhea virus (BVDV) infection results in a wide variety of clinical manifestations and is a pathogen that is able to cause huge economic losses in the cattle industry worldwide. It is important to identify cattle that are persistently infected (PI) by BVDV within the herd as early as possible because PI animals are the main reservoir of the virus. In contrast, cattle who are acutely infected (AI) with BVDV show various clinical signs, but most cattle show either mild symptoms or are asymptomatic. In general, AI and PI animals can be distinguished by repeat testing within an interval of at least 21 days. However, we found a rare case of a BVDV2-infected AI animal with long-term viral presence, making it indistinguishable from PI through two tests within an interval of 21 days. As a result, we diagnosed one infected animal as AI after 35 days from the initial sample collection via multiple analyses. Our findings recommend performing an additional test using samples that have been collected after 14–21 days from the second sample collection in cases where it is difficult to accurately differentiate an AI diagnosis from a PI diagnosis after only two tests. Additionally, our analysis exhibits that monitoring the number of copies of viruses with similar genomes in the sera by means of quantitative real-time RT-PCR through several sample collections periods might be useful to distinguish AI from PI. Furthermore, our data suggest that the AI animals with a long-term viral presence who show test results similar to those of PI animals might be the result of a coincidental combination of various factors that are present in cattle fields. These findings provide useful information that can be used to improve the diagnosis of BVDV in the field.


2017 ◽  
Vol 62 (5) ◽  
pp. 204-210
Author(s):  
T. I. Glotova ◽  
A. A. Nikonova ◽  
A. G. Glotov

Bovine viral diarrhea virus (BVDV) belongs to the genus Pestivirus, family Flaviviridae. It causes various clinical forms of infection leading to significant economic losses in beef and dairy industry worldwide. Furthermore, the virus is a contaminant of biological preparations (bovine fetal serum, continuous cell cultures, vaccines for human and veterinary medicine, interferons, trypsin, biotechnological preparations, embryos, stem cells, etc.). It is used as a test object when developing methods of decontamination. In some countries, a tool for monitoring the infection caused by the virus is vaccination based on the use of live and inactivated vaccines with varying efficiency. The antiviral compounds are a potential means of control in case of insufficient efficacy of vaccines. Their advantage for BVDV control is the ability to provide immediate protection for animals at risk in the case of an outbreak of the disease. This review summarizes the current state of knowledge about antiviral compounds against BVDV. It was noted that due to the use of advanced biomedical technologies there is a tendency to search for drugs that might be effective for antiviral therapy of BVDV, as indicated by numerous studies of new compounds and the antiviral efficacy of known drugs used in medical practice. In addition to the well-known antiviral targets for the virus, such as the RdRp, IMPDH, NS3, new targets were discovered, such as protein p7. Its mechanism of action remains to be explored. It can be concluded that there is a great potential for BVDV control through the use of antiviral drugs which has not yet implemented. The biggest obstacle for commercial implementation of identified compounds is the lack of demonstration of their efficacy in vivo. Further studies should be performed to develop a method for administering effective drugs to groups of animals.


Sign in / Sign up

Export Citation Format

Share Document